Zen Chu serves as Senior Lecturer in Healthcare Innovation at the MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology program. With Professors Martha Gray and Bill Aulet, he created and directs HST.978 MIT Healthcare Ventures graduate course and serves as faculty director for the HackingMedicine.MIT.edu healthcare technology innovation initiative. Zen actively consults health tech companies and healthcare systems adapting to global digital healthcare transformation and emerging markets.
As managing director of Accelerated Medical Ventures Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, DirectDermatology.com, and a few companies still in stealth mode.
Alongside MIT professors Shuguang Zhang, Alex Rich, Alan Grodzinsky, and Bob Langer, Zen cofounded and served as CEO for 3D-Matrix Medical Inc., a venture-backed MIT regenerative medicine company with a successful IPO in 2011. 3D-Matrix has wound-healing and drug-delivery products on the market outside of the US and multiple human clinical trials in process.
He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures, and Hewlett-Packard.
Zen earned a BS in biomedical/electrical engineering from Southern Methodist University and an MBA from Yale University. He's married to a serial entrepreneur/venture investor and they are raising three aspiring entrepreneurs in Brookline, MA.
Open MIT Office Hours: about.me/zenven